Spain Neurology Clinical Trials Market Analysis

Spain Neurology Clinical Trials Market Analysis

$ 3999

The Spain Neurology Clinical Trials market is projected to grow from $100.9 Mn in 2022 to $143.5 Mn by 2030, registering a CAGR of 4.5% during the forecast period of 2022 - 2030. The market will be driven by well-established infrastructure, skilled researchers, and access to a big patient population. The market is segmented by phase, by study design & by indication. Some of the major players include Pfizer Inc, Grifols, S.A. & Almirall, S.A.

ID: IN10ESCT005 CATEGORY: Clinical Trials GEOGRAPHY: Spain AUTHOR: Vidhi Upadhyay

Buy Now

Spain Neurology Clinical Trials Market Executive Summary

The Spain Neurology Clinical Trials market is projected to grow from $100.9 Mn in 2022 to $143.5 Mn by 2030, registering a CAGR of 4.5% during the forecast period of 2022 - 2030. The public healthcare system in Spain is mainly of excellent quality, with well-trained medical personnel. Spain has a well-developed hospital and medical centre network, including some of the most prestigious around the globe. The pharmaceutical business is one of the important contributors to the Spanish economy. The industry earned more than $ 27.7 billion in sales by 2021. In terms of revenue, Spain has the fourth-largest pharmaceutical marketplace in Europe and the eighth-largest market globally. In Spain, over 400,000 people suffer from epilepsy. About 5-10% of the population are likely to experience a seizure at some point in their lives, with up to 20% having repeated seizures. According to hospital discharge report statistics, hospitalisations for epilepsy were about 35 per 100,000 patients.

One out of every three clinical trials conducted in Europe already includes Spanish participants. Spain accounted for 4.1% of worldwide Clinical Trials output in 2021. Moreover, Spain dramatically expanded the number of Participants in the last year, reaching roughly 145 000 Patients in over 3 400 Clinical Studies. According to, there were 1,020 active or finished clinical studies linked to neurology in Spain as of September 2021. These studies include Alzheimer's disease, multiple sclerosis, Parkinson's disease, epilepsy, and stroke, among other neurological illnesses. The Spanish Agency for Medicines and Health Products (AEMPS) is the regulatory organization in charge of clinical trial authorisation and oversight in Spain.

Several of these clinical trials are being carried out in partnership with prestigious Spanish medical institutes and universities, like the Hospital Clinic of Barcelona, the Hospital Universitario Ramón y Cajal in Madrid, and the Hospital Universitario de La Princesa in Madrid. Overall, owing to its well-established infrastructure, skilled researchers, and access to a big patient population, Spain is an appealing destination for conducting neurology clinical trials.

Spain Neurology Clinical Trials Market

Market Dynamics

Market Growth Drivers

The Spanish Ministry of Health, Consumption, and Social Welfare approved a five-year National Alzheimer's Plan, which will be fulfilled in 2023. The plan covers important objectives for increasing dementia awareness, personalized medical and social care services, assistance, and rewards, and the development of research, innovation, and knowledge. These kinds of activities are anticipated to raise awareness about neurological illnesses and support more clinical trials. In Spain, neurological illnesses such as Alzheimer's, Parkinson's, epilepsy, and multiple sclerosis are on the increase. As a result, the number of people seeking therapy has increased. Since Spain offers a favourable regulatory environment for conducting clinical trials, several pharmaceutical firms have chosen to perform their clinical studies there. Many changes have been made by Spanish regulatory authorities to ease the procedure for carrying out clinical studies, making it simpler for corporations to receive regulatory permission. In recent years, the Spanish government has increased research funding, including funds for neurology research, encouraging collaboration between the local medical system and the pharmaceutical industry, which has spurred the rise of neurology clinical trials in the nation.

Market Restraints

Despite increased research funding, there is still a limited amount of funds available for clinical trials in Spain. As a result, several businesses have found it difficult to perform clinical trials in the nation, slowing the expansion of neurology clinical trials.

In Spain, acquiring subjects for clinical trials might be difficult. Patients may be reluctant to participate in clinical trials, this may make it difficult to recruit enough people to finish clinical studies, which can be a barrier to expansion. While the regulatory climate in Spain is generally supportive of clinical trials, there are several regulatory stumbling blocks that might impede the process. Getting regulatory permission may be a time-consuming and difficult procedure, which might cause clinical studies to be delayed. Several nations with advantageous regulatory regimes and well-developed research infrastructures compete with Spain. Businesses may decide to perform clinical trials in these countries, limiting the expansion of neurology clinical trials in Spain.

Competitive Landscape

Key Players

  • Pfizer Inc.
  • Novartis AG
  • Roche Holding AG
  • Sanofi S.A.
  • Merck & Co., Inc.
  • Biogen Inc.
  • Clinscience
  • Grifols, S.A. (ESP)
  • Almirall, S.A. (ESP)
  • Faes Farma, S.A. (ESP)
  • Esteve, S.A. (ESP)
  • Laboratorios Rubió, S.A. (ESP)

Notable Insights

February 2023, ZeClinics, a zebrafish-based research firm, will be able to use Almirall's cutting-edge technological facilities to speed drug development by conducting high-throughput safety and effectiveness testing.

1. Report Description of the Spain Neurology Clinical Trials Market
1.1 Research Scope and Assumption
1.2 Objective of the study
1.3 Research Methodology
1.4 Reason to buy the report

2. Spain Neurology Clinical Trials Market Executive Summary
2.1 Spain Neurology Clinical Trials Market –Industry Snapshot & key buying criteria, 2021-2030
2.2 Market Size, Growth Prospects, and Key findings

3. Market Dynamics of Spain Neurology Clinical Trials Market
3.1 Market Growth Drivers Analysis
3.2 Market Restrains Analysis

4. Spain Neurology Clinical Trials Market Segmentation

4.1 By Phase
4.1.1 Phase I
4.1.2 Phase II
4.1.3 Phase III
4.1.4 Phase IV

4.2 By Study Design Outlook
4.2.1 Epilepsy
4.2.2 Parkinson's Disease (PD)
4.2.3 Huntington's Disease 
4.2.4 Stroke
4.2.5 Traumatic Brain Injury (TBI)
4.2.6 Amyotrophic Lateral Sclerosis (ALS)
4.2.7 Muscle regeneration
4.2.4 Others

4.3 By Indication Outlook  
4.3.1 Interventional
4.3.2 Observational
4.3.3 Expanded Access

5. Spain Neurology Clinical Trials Market Share
5.1 Market Analysis, Insights, and Forecast – By Revenue

6. Competitive Landscape
6.1 Major Top Market Players

7. Key Company Profiles

7.1 Company 1
7.1.1 Overview
7.1.2 Financial Performance
7.1.3 Product & Services
7.1.4 Strategic initiatives

7.2 Company 2
7.2.1 Overview
7.2.2 Financial Performance
7.2.3 Product & Services
7.2.4 Strategic initiatives

7.3 Company 3
7.3.1 Overview
7.3.2 Financial Performance
7.3.3 Product & Services
7.3.4 Strategic initiatives

7.4 Company 4
7.4.1 Overview
7.4.2 Financial Performance
7.4.3 Product & Services
7.4.4 Strategic initiatives

7.5 Company 5
7.5.1 Overview
7.5.2 Financial Performance
7.5.3 Product & Services
7.5.4 Strategic initiatives  

8. Healthcare Policies and Regulatory Landscape
8.1 Healthcare Policies in Spain
8.2 Regulatory Framework in Spain
8.3 Pricing & Reimbursement Scenario in Spain Neurology Clinical Trials Market

9. Factors Driving Future Growth
9.1 New Trends and Development Spain Neurology Clinical Trials Market
9.2 Future Opportunities

10. Strategic Recommendations

Neurology Clinical Trials Market Segmentation

By Phase (Revenue, USD Billion):

  • Phase I
  • Phase II
  • Phase III
  • Phase IV

By Study Design Outlook (Revenue, USD Billion):

  • Epilepsy
  • Parkinson's Disease (PD)
  • Huntington's Disease
  • Stroke
  • Traumatic Brain Injury (TBI)
  • Amyotrophic Lateral Sclerosis (ALS)
  • Muscle regeneration
  • Others

By Indication Outlook (Revenue, USD Billion):

  • Interventional
  • Observational
  • Expanded Access

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.


Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:



Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.



Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.

We value your inquiry and offer free customization with every report to fulfil your exact research needs.

This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 14 March 2023

Related reports (by category)

Related reports (by geography)

subscribe to our newsletter